Norman Michael Greenberg
Plus aucun poste en cours
Postes actifs de Norman Michael Greenberg
Sociétés | Poste | Début | Fin |
---|
Historique de carrière de Norman Michael Greenberg
Anciens postes connus de Norman Michael Greenberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
ATRECA, INC. | Directeur Technique/Scientifique/R&D | 01/05/2016 | 31/03/2021 |
CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2015 | 01/05/2016 |
NMG Scientific Consulting USA | Directeur Général | 01/04/2014 | 01/05/2016 |
President | 01/04/2014 | 01/05/2016 | |
Medimmune, Inc. | Directeur Technique/Scientifique/R&D | 01/08/2011 | 01/05/2014 |
PFIZER, INC. | Directeur Technique/Scientifique/R&D | 01/06/2009 | 01/07/2011 |
Baylor College of Medicine | Corporate Officer/Principal | 01/09/1998 | 01/12/2003 |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Formation de Norman Michael Greenberg
University of Toronto | Undergraduate Degree |
University of British Columbia | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Canada | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PFIZER, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Atreca, Inc.
Atreca, Inc. BiotechnologyHealth Technology Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA. | Health Technology |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
Medimmune, Inc. | Health Technology |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
NMG Scientific Consulting USA |
- Bourse
- Insiders
- Norman Michael Greenberg
- Expérience